What is the catalog number for Saroglitazar Sulfoxide-d4?

The catalog number for Saroglitazar Sulfoxide-d4 is CS-O-16431.

What sizes are available for Saroglitazar Sulfoxide-d4?

Saroglitazar Sulfoxide-d4 is available in the following size(s): 1 Each.

Is Saroglitazar Sulfoxide-d4 in stock?

Saroglitazar Sulfoxide-d4 is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Saroglitazar Sulfoxide-d4?

The safety data sheet for Saroglitazar Sulfoxide-d4 is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-O-16431.

Saroglitazar Sulfoxide-d4

Saroglitazar Sulfoxide-d4 is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Saroglitazar. The product is supplied by Clearsynth under CAT No. CS-O-16431. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

"Saroglitazar, is a drug for the treatment of diabetic dyslipidemia and hypertriglyceridemia with Type 2 diabetes mellitus not controlled by statin therapy. Its trade name is Lipaglyn. It is also a 1,2-Diarylpyrroles derivative, which can be used in the preparation of Nonsteroidal anti-inflammatory drugs (NSAIDs) ."

Synonyms

Saroglitazar Sulfoxide-d4

Molecular Formula

C 25 H 25 D 4 NO 5 S

Molecular Weight

459.59

Additionnal Information

Saroglitazar Sulfoxide-d4 is supplied with detailed characterization data compliant with regulatory guideline. Saroglitazar Sulfoxide-d4 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Saroglitazar.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

"Saroglitazar, is a drug for the treatment of diabetic dyslipidemia and hypertriglyceridemia with Type 2 diabetes mellitus not controlled by statin therapy. Its trade name is Lipaglyn. It is also a 1,2-Diarylpyrroles derivative, which can be used in the preparation of Nonsteroidal anti-inflammatory drugs (NSAIDs) ."